INMB Research and Charts

INMB - INmune Bio Inc (Healthcare: Biotechnology)

Projected Earnings Date: 2024-08-05 (Delayed quote data 2025-01-03)

Last 5.30	Change ⇑ +0.37 (+7.40%)	Volume 408,673
	Open 5.01	High 5.42	Low 5.01

8EMA (Daily) 4.85	40EMA (Daily) 5.03	50EMA (Daily) 5.13	STO (Daily) 46.288	MACD Hist (Daily) 0.144
8EMA (Weekly) 4.993	40EMA (Weekly) 6.76	50EMA (Weekly) 7.12	STO (Weekly) 18.668	MACD Hist (Weekly) 0.158


Company Profile
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow the immune system to fight cancer. The company's pipeline products includeINKmune, INBO3, XPro1595, LIVNate, and others.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.